BCFPI mean values (SD in parentheses) divided by sex and
| Boys (n = 150) | Girls (n = 117) | 6-12 years (n = 154) | 13-17 years (n = 113) | |
|---|---|---|---|---|
| ADD | 4.15 (1.58) | 3.67 (1.74) | 3.95 (1.67) | 3.92 (1.68) |
| ADHD | 7.32 (3.01) | 6.61 (3.42) | 7.36 (3.28) | 6.54 (3.07) |
| SAD | 2.85 (2.88) | 3.29 (2.90) | 3.58 (3.07) | 2.31 (2.46) |
| GAD | 4.99 (2.99) | 5.52 (3.09) | 5.19 (3.00) | 5.27 (3.11) |
| MDD | 4.57 (3.49) | 5.06 (3.35) | 3.75 (3.12) | 6.19 (3.35) |
| CD | 1.67 (1.85) | 1.44 (1.98) | 1.91 (1.96) | 1.10 (1.73) |
| ODD | 7.35 (3.48) | 7.37 (3.30) | 7.67 (3.45) | 6.93 (3.27) |
| INT | 12.42 (7.00) | 13.87 (6.58) | 12.53 (6.89) | 13.78 (6.74) |
| EXT | 16.39 (6.65) | 15.41 (6.87) | 16.99 (6.94) | 14.67 (6.23) |
Demographic characteristics and symptom load in the study sample compared with all admitted patients
| Admitted not in study sample (n = 5641) | Study sample (n = 267) | p-value | |
|---|---|---|---|
| Child, n (%) | 2878 (50.1) | 154 (57.7) | 0.03 |
| Boys, n (%) | 3184 (53.9) | 150 (56.2) | 0.44 |
| Boys 6-12, n (%) | 1924 (32.6) | 97 (36.3) | 0.18 |
| Boys 13-17, n (%) | 1260 (21.3) | 54 819.9) | 0.55 |
| Girls 6-12, n (%) | 1108 (18.8) | 57 (21.3) | 0.27 |
| Girls 13-17, n (%) | 1616 (27.4) | 60 (22.5) | 0.07 |
| T-value, externalizing (SD) | 63 (14.2) | 68 (13.1) | < 0.001 |
| T-value, internalizing (SD) | 61 (14.5) | 64 (13.9) | < 0.001 |
Screening properties of the BCFPI and the CBCL versus a LEAD diagnosis
| BCFPI | CBCL | #Diag | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Cut* | AUC | κ | Sens | Spec | PPV | NPV | AUC | κ | ||
| ADD | 4 | 0.82 (± 0.05) | 0.48 | 0.80 | 0.68 | 0.82 | 0.65 | 174 | ||
| ADHD | 7 | 0.81 (± 0.05) | 0.40 | 0.74 | 0.68 | 0.81 | 0.58 | 0.80 | 0.44 | 174 |
| SAD | 9 | 0.90 (± 0.06) | 0.45 | 0.43 | 0.97 | 0.56 | 0.95 | 0.74 | 0.11 | 23 |
| GAD | 11 | 0.75 (± 0.12) | 0.18 | 0.19 | 0.97 | 0.27 | 0.95 | 0.72 | 0.07 | 16 |
| MDD | 7 | 0.78 (± 0.06) | 0.37 | 0.56 | 0.81 | 0.54 | 0.81 | 0.77 | 0.36 | 80 |
| CD | 6 | 0.83 (± 0.09) | 0.19 | 0.23 | 0.96 | 0.23 | 0.96 | 0.92 | 0.34 | 13 |
| ODD | 10 | 0.73 (± 0.06) | 0.31 | 0.53 | 0.78 | 0.56 | 0.75 | 0.80 | 0.43 | 93 |
| INT | 14 | 0.70 (± 0.06) | 0.29 | 0.62 | 0.67 | 0.61 | 0.68 | 120 | ||
| EXT | 13 | 0.78 (± 0.06) | 0.34 | 0.81 | 0.54 | 0.82 | 0.52 | 193 | ||
Screening properties for BCFPI versus LEAD divided into sex and age
| Boys (n = 150) | Girls (n = 117) | 6-12 years (n = 154) | 13-17 years (n = 113 | |
|---|---|---|---|---|
| ADD | 0.82 (± 0.07) | 0.80 (± 0.08) | 0.82 (± 0.08) | 0.85 (± 0.07) |
| ADHD | 0.84 (± 0.07) | 0.79 (± 0.08) | 0.84 (± 0.08) | 0.79 (± 0.08) |
| MDD | 0.76 (± 0.08) | 0.80 (± 0.08) | 0.75 (± 0.10) | 0.75 (± 0.09) |
| ODD | 0.73 (± 0.08) | 0.74 (± 0.09) | 0.69 (± 0.08) | 0.78 (± 0.09) |
| INT | 0.67 (± 0.09) | 0.72 (± 0.09) | 0.72 (± 0.08) | 0.65 (± 0.10) |
| EXT | 0.76 (± 0.09) | 0.79 (± 0.08) | 0.78 (± 0.08) | 0.75 (± 0.09) |